Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ballantyne

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|February 19, 1983
Sudden death in a marathon runnerR J Northcote, D Ballantyne
British Heart Journal|July 1, 1990
Antianginal efficacy of exercise training: a comparison with beta blockadeI C Todd, D Ballantyne
American Heart Journal|December 1, 1984
Ventricular fibrillation during ambulatory electrocardiographyR J Northcote, D Ballantyne
International Journal of Pediatric Otorhinolaryngology|April 17, 1999
'Small group' rehabilitation in adolescent cochlear implant users: learning experiencesE Bosco, L D'Agosta, D Ballantyne
Scandinavian Audiology. Supplementum|January 1, 1996
Relationship between ENT specialists and deaf communityR Filipo, E Bosco, D Ballantyne
Drugs|September 21, 2013
Dolutegravir: first global approvalAnita D Ballantyne, Caroline M Perry
Atherosclerosis|June 1, 1981
Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteinsD Ballantyne, F C Ballantyne, McMurdo
Drugs|May 7, 2014
Apremilast: first global approvalRaewyn M Poole, Anita D Ballantyne
European Heart Journal|June 1, 1996
A comparison of the effects of strength and aerobic exercise training on exercise capacity and lipids after coronary artery bypass surgeryD Wosornu, D Bedford, D Ballantyne
Clinical Cardiology|February 1, 1985
Delay in diagnosis of right atrial myxomaR J Northcote, B Sethia, D Ballantyne
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|February 19, 1983
Sudden death in a marathon runnerR J Northcote, D Ballantyne
British Heart Journal|July 1, 1990
Antianginal efficacy of exercise training: a comparison with beta blockadeI C Todd, D Ballantyne
American Heart Journal|December 1, 1984
Ventricular fibrillation during ambulatory electrocardiographyR J Northcote, D Ballantyne
International Journal of Pediatric Otorhinolaryngology|April 17, 1999
'Small group' rehabilitation in adolescent cochlear implant users: learning experiencesE Bosco, L D'Agosta, D Ballantyne
Scandinavian Audiology. Supplementum|January 1, 1996
Relationship between ENT specialists and deaf communityR Filipo, E Bosco, D Ballantyne
Drugs|September 21, 2013
Dolutegravir: first global approvalAnita D Ballantyne, Caroline M Perry
Atherosclerosis|June 1, 1981
Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteinsD Ballantyne, F C Ballantyne, McMurdo
Drugs|May 7, 2014
Apremilast: first global approvalRaewyn M Poole, Anita D Ballantyne
European Heart Journal|June 1, 1996
A comparison of the effects of strength and aerobic exercise training on exercise capacity and lipids after coronary artery bypass surgeryD Wosornu, D Bedford, D Ballantyne
Clinical Cardiology|February 1, 1985
Delay in diagnosis of right atrial myxomaR J Northcote, B Sethia, D Ballantyne
Pageof 14